2月25日，楚天科技涨2.55%，成交额2.80亿元。两融数据显示，当日楚天科技获融资买入额2773.87万 元，融资偿还1328.99万元，融资净买入1444.88万元。截至2月25日，楚天科技融资融券余额合计2.51亿 元。 截至9月30日，楚天科技股东户数2.89万，较上期增加4.10%；人均流通股19913股，较上期减少3.94%。 2025年1月-9月，楚天科技实现营业收入38.96亿元，同比减少6.60%；归母净利润8446.35万元，同比增 长145.11%。 分红方面，楚天科技A股上市后累计派现3.61亿元。近三年，累计派现1.17亿元。 机构持仓方面，截止2025年9月30日，楚天科技十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股938.65万股，相比上期减少80.06万股。安信医药健康股票A（010709）位居第八大流通股 东，持股173.38万股，为新进股东。国寿安保智慧生活股票A（001672）退出十大流通股东之列。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公 ...

证券日报网讯2月12日，迦南科技（300412）在互动平台回答投资者提问时表示，截至2026年2月10日， 公司股东人数为26753户。 ...

关注" 新华网财经 "视频号 更多财经资讯等你来看 往期推荐 腾讯"元宝分10亿"活动2月1日0点正式开启，用户最高可领万元现金红 包，官方攻略发布 据中央纪委国家监委驻中央社会工作部纪检监察组、海南省纪委监委消息，中国制药装备行业协会副秘书长遆 倩鹤 涉嫌严重违法，目前正 接受中央纪委国家监委驻中央社会工作部纪检监察组和海南省儋州市监察委员会监察调查。 （中央纪委国家监委驻中央社会工作部纪检监察组、海南省纪委监委） 来源： 中央纪委国家监委网站 亚马逊官宣裁撤1.6万个职位 ...

中国制药装备行业协会副秘书长遆倩鹤涉嫌严重违法，目前正接受中央纪委国家监委驻中央社会工作部 纪检监察组和海南省儋州市监察委员会监察调查。 （中央纪委国家监委驻中央社会工作部纪检监察组、海南省纪委监委） 中央纪委国家监委网站讯 据中央纪委国家监委驻中央社会工作部纪检监察组、海南省纪委监委消息： ...

证券日报网讯2月2日，迦南科技（300412）在互动平台回答投资者提问时表示，截至2026年1月20日， 公司股东人数为27729户。 ...

Group 1 - The core viewpoint of the article highlights that Xinhua Medical has focused its R&D expenses over the past three years on two main areas: medical devices and pharmaceutical equipment [1] - The company is pursuing core technology breakthroughs and product innovations in high-end, intelligent, and green directions, particularly in high-end radiotherapy and imaging equipment, infection control devices, minimally invasive surgical instruments and consumables, and high-end pharmaceutical formulation equipment [1] - Additionally, Xinhua Medical is expanding into cutting-edge areas such as rehabilitation intelligent equipment, continuously advancing product technology upgrades and international certifications to strengthen its core technological barriers [1]

证券日报网讯 1月30日，新华医疗在互动平台回答投资者提问时表示，公司历史上已累计承担/参与20 余项国家级科技项目，其中在"十二五""十三五""十四五"期间连续申报并获批国家重点研发计划，技术 与经验积淀深厚。"十五五"期间，公司将继续积极申报承担国家重点研发计划，聚焦医疗器械与制药装 备两大主业，围绕高端放疗影像、智慧感控、微创器械、高端制剂装备等方向，联合高校、医院及科研 院所，攻克"卡脖子"技术、推进国产化替代与前沿技术产业。 （编辑 姚尧） ...

（文章来源：证券日报） 证券日报网1月26日讯 ，楚天科技在接受调研者提问时表示，近年来，公司国际销售与服务体系团队不 断壮大，已在二十多个重点国家和地区设立了本土化的销售与服务网点，积极推行国际业务本土化战 略。公司目前主要聚焦东南亚、中东非、欧洲、美洲、印度新澳五大区域，推动高质量销售与服务落 地，依托行业稀缺的整体解决方案能力、高性价比服务及渠道优势拓展客户。2025年出口订单较2024年 实现了较好增长。 ...

Core Viewpoint - The company, Chutian Technology, expects a significant turnaround in net profit and net profit excluding non-recurring items for 2025 compared to 2024, driven by international market expansion, product differentiation strategies, and cost control measures [1] Group 1: International Market Expansion - The company is intensifying its efforts in international market expansion, with overseas business entering a rapid growth phase in regions such as Southeast Asia, the Middle East, Africa, and the Americas, leading to a significant increase in the proportion of international business in overall operations [1] Group 2: Product Differentiation and Cost Efficiency - Since the second half of 2024, the company has adopted a product differentiation strategy to enhance order quality, alongside implementing various cost reduction and efficiency improvement measures, including optimizing product solutions in R&D, reducing procurement costs in the supply chain, and improving production efficiency, which has resulted in a noticeable increase in gross margin [1] Group 3: Operational Cost Control - The company has initiated a series of refined management measures to control overall operational costs effectively, achieving significant results in 2025, with total period expenses showing a marked decrease compared to the same period in 2024 [1]

Core Viewpoint - The company, Chutian Technology, is focusing on the development of pharmaceutical robots that align with the core pharmaceutical equipment industry chain, aiming for automation and intelligence in pharmaceutical production [1] Summary by Relevant Categories Business Strategy - The company is concentrating on the clean medical core sector to promote the upgrade of pharmaceutical equipment towards unmanned and intelligent solutions, which aligns with future trends in pharmaceutical production [1] Product Development - Chutian Technology has successfully developed and implemented clean robots and sorting robots, which are adaptable to existing business scenarios [1] Competitive Advantage - The company's core competitive advantages lie in two areas: a deep understanding of the application scenarios of its business segments and a profound comprehension of the production processes in the downstream pharmaceutical industry, enabling precise matching of current pharmaceutical equipment needs [1]